Women with MS who stop taking natalizumab during pregnancy are at a significantly increased risk of relapse-related disability up to 1 year after delivery, new research shows.
Medscape Medical News
…read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
